KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Invested Capital (2016 - 2025)

Astrana Health's Invested Capital history spans 15 years, with the latest figure at $836.9 million for Q3 2025.

  • For Q3 2025, Invested Capital rose 15.5% year-over-year to $836.9 million; the TTM value through Sep 2025 reached $836.9 million, up 15.5%, while the annual FY2024 figure was $726.1 million, 17.43% up from the prior year.
  • Invested Capital for Q3 2025 was $836.9 million at Astrana Health, up from $784.0 million in the prior quarter.
  • Across five years, Invested Capital topped out at $836.9 million in Q3 2025 and bottomed at $350.1 million in Q1 2021.
  • The 5-year median for Invested Capital is $571.4 million (2023), against an average of $588.2 million.
  • The largest YoY upside for Invested Capital was 94.4% in 2021 against a maximum downside of 18.22% in 2021.
  • A 5-year view of Invested Capital shows it stood at $454.9 million in 2021, then grew by 19.79% to $544.9 million in 2022, then increased by 13.47% to $618.3 million in 2023, then increased by 17.43% to $726.1 million in 2024, then rose by 15.26% to $836.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Invested Capital are $836.9 million (Q3 2025), $784.0 million (Q2 2025), and $750.4 million (Q1 2025).